Daily practices in chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma: METESTOMAC French prospective cohort

BACKGROUND: Around 50% of gastric cancers are diagnosed at an advanced stage. Several chemotherapy regimens are now internationally validated. Few data are available on the routine daily management of advanced gastric or gastroesophageal junction cancers. We aimed to describe chemotherapy practices,...

Descripción completa

Detalles Bibliográficos
Autores principales: Manfredi, Sylvain, Dior, Marie, Bouche, Olivier, Barbier, Emilie, Hautefeuille, Vincent, Guillet, Marielle, Turpin, Justine, Bourgeois, Vincent, Helene, Dall Osto, Desgrippes, Romain, Audemar, Franck, Molin, Yann, Locher, Christophe, Chatellier, Thierry, Lecomte, Thierry, Baize, Nathalie, Lecaille, Cedric, Spaeth, Dominique, Goujon, Gael, Lepage, Come, Tougeron, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028027/
https://www.ncbi.nlm.nih.gov/pubmed/36394147
http://dx.doi.org/10.1002/cam4.5354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028027/
https://www.ncbi.nlm.nih.gov/pubmed/36394147
http://dx.doi.org/10.1002/cam4.5354

Ejemplares similares